Medicinal Bioconvergence Research Center (Biocon) was initiated in 2010 as one of the Global Frontier Projects that are by Ministry of Science, ICT and Future Planning. Our goal is to build an integrated research platform namely “The Target Factory” to develop well-validated packages of targets and leads that can be used in biotech and pharmaceutical industry. Biocon consists of the experts in target identification, drug design, drug screening and disease modeling. The results from these four specialist groups are converged into integration core group. The matured packages of target and lead are then relayed to the group for translation and development (named TRADE). We will do our best to establish Biocon the world’s first and best target factory that systematically translate original science and technology to new therapy and diagnosis for future medicine.
Specialists in Molecular and Cell Biology
Specialists in Biochemistry
Specialists in Antibody and Peptide Engineering
Specialists in Assay Development
Specialists in Preclinical Development
Specialists in Proteomics